Published 30-Day FRN

lotter on DSK11XQN23PROD with NOTICES1

90834

Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices

• P–AKT–S473 expression in Figure
3C in Genes Cancer 2014 and lanes 1–
4 of DEPTOR expression in Figure 3C of
Cancer Res. 2016 with resizing.
• Lanes 7–9 of p70S6K1 expression in
Figure 1A of Genes Cancer 2014 and
DEPTOR expression in Figure 4C of
Cancer Res. 2016.
• STAT3 associated kinase activity in
Figure 4A and lanes 1–4 of p110 mu
associated kinase activity in Figure 5B
of Oncogene 2004.
• Lanes 7–8 of ACTIN expression in
Figure 1A and lanes 7–8 of ACTIN
expression in Figure 1C of PLoS One
2014.
• Lanes 3–4 of P–MNK and T–MNK
expression in Figure 1C of PloS One
2014 and lanes 1–2 of FKHD–P and
FKHD–T expression (top panels) in
Figure 1B of Mol Cancer Ther. 2005.
• Lanes 4–8 of P–AKT (S473) and
actin expression in Figure 2A of Mol
Cancer Ther. 2011 and AKT and S6K
expression in Figure 1F of PloS One
2017 with a 180 degree rotation of the
P–AKT/AKT panels.
• Lanes 1–2 of T–HSP27 expression
and lanes 4–5 of GAPDH expression in
Figure 2B of Oncogene 2013.
• Lanes 1–3 of p–erk and lanes 2–4 of
t-erk expression in Figure 3B and lanes
1–3 of erk(T202/Y204) and erk
expression in Figure 4A of J Biol Chem.
2012.
• a-tubulin expression in Figure 4D
and 4E of Genes Cancer 2014.
• C-myc expression in Figure 1B and
lanes 1–4 of T-p70 expression in Figure
1E of Oncogene 2016.
• T–4E–BP1 (a, b and g
phosphorylated forms) expression
(middle panel) and lanes 1–4 of T–4E–
BP (a, b and g phosphorylated forms)
expression (right panel) of
Supplemental Figure 2A of Oncogene
2016.
• T–S6 expression and C–myc
expression in Figure 1F of Oncogene
2016.
• Lanes 2–5 of MNK–P and MNK–T
expression (left panel) in Figure 3A and
ERK–T and Hsp–27–T expression in
Figure 4A of Oncogene 2016.
• MNK1, MNK2 and GAPDH
expression in Figure 3E of Oncogene
2016 and MNK1, MNK2 and GAPDH
expression in Figure 3A of PloS One
2014.
• ire–1–total expression (right panel)
in Figure 5B of Mol Cancer Res. 2016
and mTor expression in Figure 8A of
Genes Cancer 2014 with resizing.
• The right panel of ACTIN
expression in Figure 2A and the right
panel of ACTIN expression in Figure 2g
of Mol Cancer Ther. 2019.
• Lanes 1–6 of DEPTOR and mTOR
expression in Figure 1A of Genes

VerDate Sep<11>2014

17:17 Nov 15, 2024

Jkt 265001

Cancer 2014 and DEPTOR and mTor
expression in Figure 6A of Mol Cancer
Ther. 2019.
• IRS–1 expression in lanes 4–5 and
lanes 8–9 in Figure 6B of Mol Cancer
Ther. 2005.
• AKT expression (bottom panel) in
Figure 1Aand lanes 7–9 of IRS–1
expression in Figure 6B of Mol Cancer
Ther. 2005.
• Lanes 4–6 of IGF–R expression and
lanes 4–6 of FLAG expression in Figure
5B of Mol Cancer Ther. 2005 with a 180degree rotation.
• Lanes 2–3 of AKT–T expression
(4th panel) in and lanes 1–2 of AKT–T
expression (6th panel) in Figure 1C of
Mol Cancer Ther. 2005.
• Lanes 1–2 of AKT–P expression
(top panel) and lanes 1–2 of AKT–P
expression (5th panel) in Figure 1E of
Mol Cancer Ther. 2005.
• Lanes 1–3 and lanes 5–7 of FKH–T
expression in Figure 3C of Blood 2003.
• Lane 1 of p70 expression and
Ser411 expression in Figure 4B and lane
4 of Ser411 expression and lanes 1–2 of
Ser411 expression in Figure 4c of Blood
2003.
• Lanes 1 and 3 of ERK–P expression
and lanes 2 and 4 of ERK–T expression
in Figure 2C of Blood 2003.
Based on these findings of research
misconduct, which the Respondent did
not appeal, the Department has imposed
the following corrective actions:
(1) Prohibition from conducting VA
research for at least 2 years;
(2) Notification to the relevant
journals of the research misconduct
findings.
Signing Authority
Denis McDonough, Secretary of
Veterans Affairs, signed and approved
this document on November 12, 2024,
and authorized the undersigned to sign
and submit the document to the Office
of the Federal Register for publication
electronically as an official document of
the Department of Veterans Affairs.
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy
& Management, Office of General Counsel,
Department of Veterans Affairs.
[FR Doc. 2024–26756 Filed 11–15–24; 8:45 am]
BILLING CODE 8320–01–P

PO 00000

Frm 00172

Fmt 4703

Sfmt 4703

DEPARTMENT OF VETERANS
AFFAIRS
[OMB Control No. 2900–0012]

Agency Information Collection Activity
Under OMB Review: Application for
Cash Surrender or Policy Loan and
Application for Cash Surrender
(Docusign)
Veterans Benefits
Administration, Department of Veterans
Affairs.
ACTION: Notice.
AGENCY:

In compliance with the
Paperwork Reduction Act (PRA) of
1995, this notice announces that the
Veterans Benefits Administration,
Department of Veterans Affairs, will
submit the collection of information
abstracted below to the Office of
Management and Budget (OMB) for
review and comment. The PRA
submission describes the nature of the
information collection and its expected
cost and burden, and it includes the
actual data collection instrument.
DATES: Comments and
recommendations for the proposed
information collection should be sent by
December 18, 2024.
ADDRESSES: To submit comments and
recommendations for the proposed
information collection, please type the
following link into your browser:
www.reginfo.gov/public/do/PRAMain,
select ‘‘Currently under Review—Open
for Public Comments’’, then search the
list for the information collection by
Title or ‘‘OMB Control No. 2900–0012.’’
FOR FURTHER INFORMATION CONTACT: VA
PRA information: Maribel Aponte, (202)
461–8900, vacopaperworkreduact@
va.gov.
SUPPLEMENTARY INFORMATION:
Title: Application for Cash Surrender
or Policy Loan (VA Form 29–1546).
Application for Cash Surrender (VA
Form 29–1546e—DocuSign).
OMB Control Number: 2900–0012—
https://www.reginfo.gov/public/do/
PRASearch.
Type of Review: Extension without
change of a currently approved
collection.
Abstract: The Application for Cash
Surrender or Policy Loan solicits
information needed from Veterans to
apply for cash surrender value or policy
loan on his/her insurance. The VA Form
29–1546e has been added to this
collection. This is an electronic version
of the 29–1546 but is for cash surrender
only. This form was created so Veterans
can apply for a cash surrender of their
policy online. This will not affect the
number of respondents but will make it
SUMMARY:

E:\FR\FM\18NON1.SGM

18NON1

Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices

lotter on DSK11XQN23PROD with NOTICES1

easier and reduce the time it takes for
Veterans to receive the cash value of
their policy. The information on this
form is required by law, 38 U.S.C. 1906
and 1944, 38 CFR 6.115, 6.116, 6.117,
8.27, 6.100, 6.101 and 8.28.
An agency may not conduct or
sponsor, and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number. The Federal Register

VerDate Sep<11>2014

17:17 Nov 15, 2024

Jkt 265001

Notice with a 60-day comment period
soliciting comments on this collection
of information was published at 89 FR
73507, September 10, 2024.
Affected Public: Individuals or
Households.
Estimated Annual Burden: 4,939
hours.
Estimated Average Burden per
Respondent: 10 minutes.
Frequency of Response: Upon
Request.

PO 00000

Frm 00173

Fmt 4703

Sfmt 9990

90835

Estimated Number of Respondents:
29,636.
Authority: 44 U.S.C. 3501 et seq.
Maribel Aponte,
VA PRA Clearance Officer, Office of
Enterprise and Integration, Data Governance
Analytics, Department of Veterans Affairs.
[FR Doc. 2024–26799 Filed 11–15–24; 8:45 am]
BILLING CODE 8320–01–P

E:\FR\FM\18NON1.SGM

18NON1